Proteomics and blockbuster drugs Lotte Bjerre Knudsen, DMSc is chief scientific advisor at Novo Nordisk, the company behind the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide sold under the brand names Ozempic, Rybelsus, and Wegovy
Adherence and Costs In manufacturer-sponsored trials of GLP-1s for obesity, reported adherence (sustained use) has ranged from 83% to 88% at 66-68 weeks
By facilitating removal of potentially toxic acyl groups and stabilizing cellular membranes, levocarnitine may support metabolic flexibility and protects against accumulation of organic acids
Origin and identity BPC-157 partial sequence of a gastric protein BPC-157 is a 15-amino-acid peptide with the sequence GEPPPGKPADDAGLV
Dermoscopy allows better management of nail pigmentation
Symptom resolution varied with discontinuation or continued therapy